Issues with RNF43 antibodies to reliably detect intracellular location

RNF43 is an important negative regulator of β-catenin signaling by removing Wnt-receptors from the membrane. It is often mutated in cancers, leading to aberrant Wnt-dependent nuclear translocation of β-catenin. RNF43 has also been suggested to regulate β-catenin signaling directly within the nucleus, among other proposed nuclear functions. Given the importance of RNF43 in regulating Wnt/β-catenin signaling and its potential therapeutic relevance, a proper understanding of RNF43 biology is required. However, the presumed nuclear location is mainly based on available antibodies. These same antibodies have also been used extensively for immunoblotting or immunohistochemical purposes. However, a proper evaluation of their quality to reliably detect endogenous RNF43 has not been performed. Here, using genome editing we have generated a cell line that entirely misses RNF43 exons 8 and 9, encoding the epitopes of commonly used RNF43 antibodies. Using this clone in addition to various other cell line tools, we show that four RNF43 antibodies only yield non-specific signals when applied in immunoblotting, immunofluorescence and immunohistochemical experiments. In other words, they cannot reliably detect endogenous RNF43. Our results suggest that the nuclear staining patterns are an antibody artifact and that RNF43 is unlikely to localize within the nucleus. More generally, reports using RNF43 antibodies should be interpreted with caution, at least for the RNF43 protein aspects described in these papers.

[1]  H. Behrens,et al.  The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent , 2023, Scientific Reports.

[2]  Hao Li,et al.  Combining expression of RNF43 and infiltration level of CD163 + tumor associated macrophage predicts prognosis of clear cell renal cell carcinoma , 2022, Cancer medicine.

[3]  Masafumi Nakamura,et al.  RNF43 as a predictor of malignant transformation of pancreatic mucinous cystic neoplasm , 2022, Virchows Archiv.

[4]  K. Souček,et al.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy , 2021, eLife.

[5]  Chen-zhou Wu,et al.  Wnt/β-catenin signaling in cancers and targeted therapies , 2021, Signal Transduction and Targeted Therapy.

[6]  W. Weichert,et al.  Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response , 2020, Cellular and molecular gastroenterology and hepatology.

[7]  C. Niehrs,et al.  R-spondins are BMP receptor antagonists in Xenopus early embryonic development , 2020, Nature Communications.

[8]  M. Maurice,et al.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer , 2020, Nature reviews. Cancer.

[9]  R. Smits,et al.  The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition , 2020, Cancer Research.

[10]  K. Nakayama,et al.  A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis , 2020, Nature Communications.

[11]  R. Smits,et al.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers , 2020, Oncogene.

[12]  M. Unno,et al.  Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes , 2020, The Journal of pathology.

[13]  Soohyung Park,et al.  The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis , 2019, Scientific Reports.

[14]  T. Okumura,et al.  Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. , 2019, Gastroenterology.

[15]  M. Vieth,et al.  Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells. , 2018, Carcinogenesis.

[16]  A. Wagner,et al.  A novel tissue‐based ß‐catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors , 2018, Pediatric blood & cancer.

[17]  V. Neumeister,et al.  The ABCs of finding a good antibody: How to find a good antibody, validate it, and publish meaningful data , 2017, F1000Research.

[18]  B. Leggett,et al.  RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis , 2016, Oncotarget.

[19]  Xiaomo Jiang,et al.  Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer , 2016, Cancers.

[20]  N. Yoo,et al.  Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers. , 2015, Human pathology.

[21]  Haiyang Xie,et al.  Association of RNF43 with cell cycle proteins involved in p53 pathway. , 2015, International journal of clinical and experimental pathology.

[22]  Michael Neumaier,et al.  The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane , 2015, Science Signaling.

[23]  H. Xi,et al.  RNF43 Inhibits Cancer Cell Proliferation and Could be a Potential Prognostic Factor for Human Gastric Carcinoma , 2015, Cellular Physiology and Biochemistry.

[24]  A. Fukui,et al.  Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling , 2015, Molecular and Cellular Biology.

[25]  Andreas Plückthun,et al.  Reproducibility: Standardize antibodies used in research , 2015, Nature.

[26]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[27]  L. Florens,et al.  The nuclear envelope proteome differs notably between tissues , 2012, Nucleus.

[28]  H. Clevers,et al.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.

[29]  T. Sugiura,et al.  A cancer-associated RING finger protein, RNF43, is a ubiquitin ligase that interacts with a nuclear protein, HAP95. , 2008, Experimental cell research.

[30]  L. Florens,et al.  Isolation, Proteomic Analysis, and Microscopy Confirmation of the Liver Nuclear Envelope Proteome. , 2016, Methods in molecular biology.